TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,670 | -61.3% | 14,195 | +15.1% | 0.16% | -60.9% |
| Q2 2023 | $306,401 | +117746.5% | 12,335 | -28.6% | 0.41% | +7.8% |
| Q1 2023 | $260 | +23.2% | 17,276 | -3.1% | 0.38% | +58.7% |
| Q4 2022 | $211 | -99.8% | 17,826 | +3.6% | 0.24% | +126.2% |
| Q3 2022 | $102,000 | -28.7% | 17,204 | +14.6% | 0.11% | +1.9% |
| Q1 2022 | $143,000 | -50.0% | 15,018 | -0.3% | 0.10% | -45.3% |
| Q4 2021 | $286,000 | -43.4% | 15,062 | -0.7% | 0.19% | -50.6% |
| Q3 2021 | $505,000 | -13.4% | 15,175 | +1.0% | 0.39% | -14.9% |
| Q2 2021 | $583,000 | -19.3% | 15,029 | +0.3% | 0.46% | -25.2% |
| Q1 2021 | $722,000 | +862.7% | 14,984 | -15.0% | 0.61% | +426.7% |
| Q2 2020 | $75,000 | – | 17,628 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |